Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on LinkedIn:
“Truly honored to be invited to speak in Milan Italy this past week at the European Hematology Association annual meeting. I was able to deliver our group’s oral presentation on our original dataset: Ph2 international clinical trial CADENZA PVEK for BPDCN CD123.”
